QQ客服 官方微博 反馈留言

	Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial
	Lu, Jin; Lee, Jae H.; Huang, Shang-Yi; Qiu, Lugui; Lee, Je-Jung; Liu, Ting; Yoon, Sung-Soo; Kim, Kihyun; Shen, Zhi X.; Eom, Hyeon S.
	2017
卷号	176期号:5页码:743-749
关键词	lenalidomide multiple myeloma transplant-ineligible newly diagnosed Asia
ISSN号	0007-1048
DOI	10.1111/bjh.14465
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6368646
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Lu, Jin,Lee, Jae H.,Huang, Shang-Yi,et al. Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial[J],2017,176(5):743-749.
APA	Lu, Jin.,Lee, Jae H..,Huang, Shang-Yi.,Qiu, Lugui.,Lee, Je-Jung.,...&Facon, Thierry.(2017).Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial.,176(5),743-749.
MLA	Lu, Jin,et al."Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial".176.5(2017):743-749.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。